NaturalShrimp, Inc. developed and patented the first shrimp-focused commercially operational Recirculating Aquaculture System (RAS). Funded by the Fisheries Research and Development Corporation (FRDC) and the Australian Prawn Farmers Association, this system was developed to evaluate the company’s patented electrocoagulation technology for the coagulation of microalgae and reduction of total nitrogen in wastewater.
NASF-AESF Foundation selected a project that demonstrated the problem of per- and polyfluoroalkyl substances (PFAS) and related chemicals in plating wastewater streams. It also stated advanced methods to eliminate PFAS from the water via electrooxidation and electrocoagulation.
Author Credits: Smruti Ranjan, Rajrani Baghel
Report ID: 5486
Published Date: Jan 03, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing adoption of automation and Internet of Things are the major factors driving the growth of the electrocoagulation market.
The market size of electrocoagulation is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.
The major players in the market are Powell Water Systems, Genesis Water Solutions, Nijhuis Industries, SONNEK Engineering, VentilAQUA, Enpurion Water Solutions, NASF-AESF, Boydel Wastewater Technologies Inc., F & T Water Solutions LLC, and others.
The chemicals & pharmaceuticals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.